CB vs CORT · P/E 14, rev $59.40B vs P/E 199, rev $675.0M
Chubb Ltd (CB) versus Corcept Therapeutics Incorporated (CORT) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
CB currently screens at market cap $114.26B and trailing P/E 13.7. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Not investment advice. Open the CB and CORT stock pages for the full models.
Not investment advice.